The catalytic activity of Abl1 single and compound mutations: Implications for the mechanism of drug resistance mutations in chronic myeloid leukaemia-Reference-Cited by-同舟云学术

The catalytic activity of Abl1 single and compound mutations: Implications for the mechanism of drug resistance mutations in chronic myeloid leukaemia

Published:2019-04 Issue:4 Volume:1863 Page:732-741
ISSN:0304-4165
Container-title:Biochimica et Biophysica Acta (BBA) - General Subjects
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - General Subjects

Author:

Georgoulia Panagiota S.^ORCID,Todde Guido^ORCID,Bjelic Sinisa^ORCID,Friedman Ran^ORCID

Funder

Swedish Cancer Society

Crafoord Foundation

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Biophysics

Reference68 articles.

1. Signaling pathways activated by oncogenic forms of Abl tyrosine kinase;Zou;J. Biol. Chem.,1999

2. Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec®, Gleevec™);Henkes;Ther. Clin. Risk Manag.,2008

3. Targeting cancer with small molecule kinase inhibitors;Zhang;Nat. Rev. Cancer,2009

4. Pushing the limits of targeted therapy in chronic myeloid leukaemia;O'hare;Nat. Rev. Cancer,2012

5. Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia;Shah;Cancer Cell,2002

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond IC₅₀- A computational dynamic model of drug resistance in enzyme inhibition treatment;2024-03-26

2. Interplay of mutations, alternate mechanisms, and treatment breaks in leukaemia: Understanding and implications studied with stochastic models;Computers in Biology and Medicine;2024-02

3. Trans vs. cis: a computational study of enasidenib resistance due to IDH2 mutations;Physical Chemistry Chemical Physics;2024

4. The Emerging Role of Molecular Dynamics Simulations in Cancer Research;Comprehensive Computational Chemistry;2024

5. Resistance to a tyrosine kinase inhibitor mediated by changes to the conformation space of the kinase;Physical Chemistry Chemical Physics;2023